Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
14,269
Total Claims
$1.2M
Drug Cost
1,028
Beneficiaries
$1,138
Cost/Patient
Risk Score Breakdown 12/100
Score components are additive. Read full methodology
Peer Comparison vs. 7,389 General Practice providers
-95%
Opioid rate vs peers
0.1% vs 2.5% avg
+1%
Cost per patient vs peers
$1,138 vs $1,128 avg
+53%
Brand preference vs peers
12.8% vs 8.4% avg
Opioid Prescribing
0.1%
Opioid Rate
17
Opioid Claims
$97
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,815 claims · $883K
Generic: 12,330 claims · $279K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Insulin Glargine,hum.Rec.Anlog | 79 | $88K |
| Semaglutide | 56 | $70K |
| Dapagliflozin Propanediol | 58 | $70K |
| Apixaban | 58 | $69K |
| Sitagliptin Phosphate | 52 | $64K |
| Fluticasone/Umeclidin/Vilanter | 45 | $40K |
| Rivaroxaban | 48 | $40K |
| Empagliflozin | 23 | $37K |
| Dulaglutide | 21 | $36K |
| Insulin Degludec | 30 | $31K |
| Sitagliptin Phos/Metformin Hcl | 17 | $26K |
| Sitagliptin Phos/Metformin Hcl | 14 | $18K |
| Budesonide/Formoterol Fumarate | 33 | $18K |
| Linaclotide | 22 | $15K |
| Tiotropium Bromide | 15 | $15K |
Prescribing Profile
Patient Profile
73
Avg Age
52%
Female
1.11
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About